Smoking and Oral Contraceptives: Can You Take Them Together?

Critical — Potentially Dangerouscontraindication
Learn about each ingredient:SmokingOral Contraceptives

Quick answer

Smoking while using estrogen-containing oral contraceptives synergistically increases the risk of serious cardiovascular events including myocardial infarction, stroke, and venous thromboembolism. The risk is especially pronounced in women over 35 and increases with the number of cigarettes smoked.

Women over 35 who smoke should not use combined oral contraceptives containing estrogen; switch to a progestin-only method, non-hormonal contraception, or stop smoking before continuing combined hormonal contraception. Discuss alternatives with your prescriber.

What happens when you take smoking with oral contraceptives?

Combining cigarette smoking with combined oral contraceptives that contain estrogen creates a synergistic increase in cardiovascular risk. This is not a simple additive effect — each behavior independently raises the risk of blood clots, heart attack, and stroke, but together the risk multiplies. This interaction is so well established that the U.S. Food and Drug Administration requires a black box warning on every package of combined hormonal contraceptives in the United States.

The mechanism involves multiple pathways. Estrogen-containing contraceptives increase the production of clotting factors in the liver, raising baseline thrombosis risk. Smoking damages the endothelial lining of blood vessels, promotes platelet aggregation, increases fibrinogen levels, raises blood pressure, and contributes to atherosclerosis. When both are present, the vascular system is simultaneously primed to clot and exposed to damaged vessel walls — a recipe for arterial and venous thrombotic events.

Research has quantified the danger. One landmark analysis found that the combination of oral contraceptive use and smoking increased the risk of acute myocardial infarction by a ratio of about 10 compared with women who neither smoked nor used the pill. The risk rises further with age, with the number of cigarettes smoked per day, and with higher estrogen doses in the contraceptive formulation.

Why is this important?

Cardiovascular events in young women taking the pill are uncommon, but when they occur they can be catastrophic — sudden cardiac death, disabling stroke, pulmonary embolism, or deep vein thrombosis. Most of these events in oral contraceptive users are thrombotic in nature, meaning they involve abnormal blood clotting rather than slow atherosclerotic narrowing. A clot that forms in a deep leg vein can travel to the lungs within minutes. A clot in a cerebral artery can cause permanent neurological damage.

The risk is age-stratified. In women under 35 who smoke fewer than 15 cigarettes per day, the absolute risk remains low, although it is still elevated above non-smokers. After age 35, the underlying cardiovascular risk of smoking accelerates sharply, and the combination with estrogen becomes dangerous enough that most prescribing guidelines treat it as an absolute contraindication. The World Health Organization Medical Eligibility Criteria classify combined hormonal contraception in women aged 35 or older who smoke 15 or more cigarettes per day as Category 4 — a condition where the method should not be used.

Other risk factors compound the danger. Women who carry the factor V Leiden mutation, who have a history of migraine with aura, who have hypertension, or who are obese face still higher risk when smoking is added to estrogen-containing contraception. Even women under 35 with these risk factors may be advised against combined hormonal methods if they smoke.

What should you do?

If you smoke and are using or considering combined oral contraceptives, talk to your healthcare provider about safer options. The simplest answer is to stop smoking, which restores eligibility for combined hormonal contraception and dramatically reduces cardiovascular risk regardless of birth control choice. If quitting smoking is not feasible immediately, consider switching to a method that does not contain estrogen.

Progestin-only options include the mini-pill, the contraceptive implant, hormonal IUDs, and depot medroxyprogesterone acetate injections. These methods do not carry the same thrombotic risk as estrogen-containing methods and are generally considered safe for women who smoke. Non-hormonal options include the copper IUD, barrier methods, and fertility awareness methods. Each has its own efficacy and side-effect profile that should be discussed with a provider.

If you are over 35 and smoke any amount, most clinical guidelines recommend against combined oral contraceptives, the patch, or the vaginal ring. If you are under 35 and smoke fewer than 15 cigarettes per day, combined methods may still be considered, but only after a candid conversation about cardiovascular risk and a plan to quit smoking. Anyone using these products should know the warning signs of a thrombotic event: severe leg pain or swelling, sudden shortness of breath, chest pain, severe headache, vision changes, or weakness on one side of the body. Any of these warrants immediate emergency evaluation.

Which specific products are affected?

This interaction applies to all combined hormonal contraceptives — products that contain both estrogen (usually ethinyl estradiol or estradiol valerate) and a progestin. The list includes combined oral contraceptive pills sold under many brand names such as Yaz, Yasmin, Loestrin, Ortho Tri-Cyclen, Lo Loestrin Fe, Junel, Microgestin, Sprintec, and many generics. It also includes the contraceptive patch (Xulane, Twirla, Ortho Evra) and the vaginal ring (NuvaRing, Annovera).

Progestin-only methods are not subject to the same warning. These include the mini-pill (norethindrone, drospirenone-only products like Slynd), the etonogestrel implant (Nexplanon), levonorgestrel intrauterine systems (Mirena, Kyleena, Liletta, Skyla), and depot medroxyprogesterone acetate (Depo-Provera). Copper IUDs (ParaGard) contain no hormones at all and are considered safe for smokers of any age.

Smoking includes cigarettes, cigars, pipes, and most authorities extend the concern to heavy use of vaping products containing nicotine, though the evidence base for vaping is less mature than for combustible tobacco. Marijuana smoking is treated separately in clinical guidelines but is generally not considered a contraindication to combined hormonal contraception in the same way that tobacco is.

The bottom line

Smoking and combined hormonal contraceptives are a dangerous combination, especially after age 35. The FDA black-box warning is not theoretical — it reflects real, measured increases in heart attack, stroke, and blood clot risk. If you smoke and use the pill, patch, or ring, talk to your prescriber about either quitting smoking or switching to a progestin-only or non-hormonal method. Do not stop your contraception abruptly without a backup plan, and seek emergency care immediately if you develop chest pain, severe leg pain, sudden shortness of breath, or stroke-like symptoms.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Oral Contraceptives + St. John's Wort

critical

St. John's Wort induces CYP3A4 and P-glycoprotein, which accelerates the metabolism of ethinyl estradiol and progestins in combined oral contraceptives. Clinical trials have documented breakthrough bleeding and reduced contraceptive hormone exposure when the two are combined, raising the risk of ovulation and unintended pregnancy.

Oral Contraceptives + Magnesium

moderate

Several studies have shown that combined oral contraceptive use is associated with lower serum magnesium levels, possibly through estrogen-related shifts in intracellular and extracellular distribution. Low magnesium can contribute to fatigue, premenstrual symptoms, and may modestly elevate venous thromboembolism risk in pill users.

Oral Contraceptives + Vitamin B6

moderate

Combined oral contraceptives lower pyridoxal 5'-phosphate (the active form of vitamin B6) by altering tryptophan metabolism and increasing B6 turnover. Long-term pill users have lower B6 status than non-users, which may contribute to mood symptoms in some women.

Oral Contraceptives + Folate

moderate

Oral contraceptive use is associated with lower plasma and red blood cell folate levels, likely through increased turnover and urinary excretion. Because pregnancies can occur shortly after stopping the pill, low folate stores increase the risk of neural tube defects in any unplanned conception.

Caffeine + Oral Contraceptives

moderate

Ethinyl estradiol in oral contraceptives inhibits CYP1A2, the enzyme that metabolizes caffeine. This roughly doubles caffeine's area-under-the-curve and prolongs its half-life, intensifying jitteriness, insomnia and palpitations.

Aspirin + Fish Oil

low

Omega-3 fatty acids in fish oil reduce platelet aggregation and prolong bleeding time slightly, theoretically adding to aspirin's antiplatelet effect. Clinical trials, however, consistently show no clinically significant increase in major bleeding even with high-dose fish oil added to aspirin.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free